arrow
M

Murthy, Srinivas

Saint Vincent's University Hospital
H指数:0
被引数:244

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial

COVID-19重症患者中的中剂量肝素血栓预防:一项随机临床试验

2026-07-012
OAAI
Molecular Bottom-Up Design of Single-Site Copper-Palladium Catalysts for Selective Glycerol Electro-Oxidation
2026-01-010
OAAI
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial

托珠单抗、萨利鲁单抗和阿那白滞素在危重症COVID-19患者中的应用:一项随机、对照、开放标签、适应性平台试验

THORAX
IF7.7
2025-05-130
PRE
Family member experience with restricted family presence in Canadian PICUs: an interpretive descriptive study
2024-11-290
OAAI
Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical Trials
2024-10-013
PRE
The Diversity of Research Participants in Randomized Controlled Trials and Observational Studies Conducted by the Canadian Critical Care Trials Group

加拿大重症监护试验小组进行的随机对照试验和观察性研究的研究参与者的多样性

2024-09-010
PRE
The association of antiplatelet agents with mortality among patients with non-COVID-19 community-acquired pneumonia: a systematic review and meta-analysis
2024-07-010
OAAI
The Rise of Adaptive Platform Trials in Critical Care

重症监护中适应性平台试验的兴起

2024-03-015
OAAI
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia
2024-02-272
OAAI
Canadian Critical Care Society position statement on reconciliation, decolonization, and Indigenous engagement
2024-02-080
PRE
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (vol 12, 2349, 2021)

羟氯喹和氯喹在新型冠状病毒肺炎中的死亡率结果: 一项随机试验的国际合作荟萃分析 (第12卷,2349,2021卷)

2024-02-050
OAAI
Simvastatin in Critically Ill Patients with Covid-19

辛伐他汀在重症新型冠状病毒肺炎患者中的应用

2023-12-2123
OAAI